J. Whang‐Peng

2.7k citations

46 papers · 2.2k indexed · 1 hit paper · h-index 22

Molecular Biology top 10%
Oncology top 5%
Hematology top 2%
Genetics top 5%
Cancer Research top 5%

Co-authors: C. S. Kao-Shan Adi F. Gazdar John D. Minna Paul A. Bunn D. N. Carney Tor Knutsen Merrill E. Goldsmith Kenneth H. Cowan
Topics: Acute Myeloid Leukemia Research (15 papers)DNA Repair Mechanisms (7 papers)Acute Lymphoblastic Leukemia research (7 papers)
Cited by: Hematology Oncology Cancer Research
Journals: Science Proceedings of the National Academy of Sciences The Lancet
Partner nations: United States United Kingdom India

In The Last Decade

J. Whang‐Peng

45 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Specific Chromosome Defect Associated with Human Small-Cell Lung Cancer: Deletion 3p(14-23)

1982 381 citations J. Whang‐Peng, Paul A. Bunn et al. profile →

Peers

Countries citing papers authored by J. Whang‐Peng

Since Specialization

Citations

This map shows the geographic impact of J. Whang‐Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Whang‐Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Whang‐Peng more than expected).

Fields of papers citing papers by J. Whang‐Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Whang‐Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Whang‐Peng. The network helps show where J. Whang‐Peng may publish in the future.

Co-authorship network of co-authors of J. Whang‐Peng

This figure shows the co-authorship network connecting the top 25 collaborators of J. Whang‐Peng. A scholar is included among the top collaborators of J. Whang‐Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Whang‐Peng. J. Whang‐Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Renal cell carcinoma 1995 ·Cancer Genetics and Cytogenetics ·(unknown),James R. Gnarra,Shihui Liu,Tor Knutsen,W. Marston Linehan,J. Whang‐Peng	32
2	Molecular genetic characterization of neuroendocrine lung cancer cell lines. 1995 ·PubMed ·(unknown),Hiltrud Brauch,Tor Knutsen,B. E. Johnson,Marion M. Nau,Tetsuya Mitsudomi,Chun-Ming Tsai,J. Whang‐Peng,B. Zbar,F Kaye	41
3	Absence of hereditary p53 mutations in 10 familial leukemia pedigrees. 1992 ·Journal of Clinical Investigation ·Carolyn A. Felix,D D’Amico,Tetsuya Mitsudomi,Marion M. Nau,(unknown),Joseph F. Fraumeni,Diane E. Cole,(unknown),Gregory H. Reaman,J. Whang‐Peng	34
4	Cytogenetic studies in subgroups of rhabdomyosarcoma 1992 ·Genes Chromosomes and Cancer ·J. Whang‐Peng,Tor Knutsen,Karl S. Theil,Marc E. Horowitz,Timothy J. Triche	90
5	Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia 1989 ·Cancer Genetics and Cytogenetics ·Clara D. Bloomfield,Lorna M. Secker‐Walker,(unknown),Herman Van den Berghe,Albert de la Chapelle,Tapani Ruutu,Giuliana Alimena,O. Margaret Garson,H M Golomb,J D Rowley,Yasuhiko Kaneko,J. Whang‐Peng,E. L. Prigogina,Preben Philip,A. A. Sandberg,SylviaD. Lawler,Felix Mitelman	126
6	Cytogenetic studies of 21 patients with acute lymphoblastic leukemia in relapse 1989 ·Cancer Genetics and Cytogenetics ·Lorna M. Secker‐Walker,Giuliana Alimena,C. D. Bloomfield,Yasuhiko Kaneko,J. Whang‐Peng,DC Arthur,Albert de la Chapelle,B.R. Reeves,J D Rowley,SylviaD. Lawler,F. Mitelman	19
7	Retention of Chromosome 3 in Extrapulmonary Small Cell Cancer Shown by Molecular and Cytogenetic Studies 1989 ·JNCI Journal of the National Cancer Institute ·Bruce E. Johnson,J. Whang‐Peng,Susan L. Naylor,Berton Zbar,Hiltrud Brauch,(unknown),(unknown),Emma Russell,Miyoung Nam,Adi F. Gazdar	48
8	Deletion of 3(p14p23) in Secondary Erythroleukemia Arising in Long-Term Survivors of Small Cell Lung Cancer 1988 ·JNCI Journal of the National Cancer Institute ·J. Whang‐Peng,(unknown),John D. Minna,Martin D. Abeloff,E C Bradley,Robert C. Young,(unknown)	10
9	Development of a second clonally discrete Burkitt's lymphoma in a human immunodeficiency virus-positive homosexual patient 1988 ·Blood ·Francisco Barriga,J. Whang‐Peng,(unknown),(unknown),Elaine S. Jaffe,J Cossman,I T Magrath	1
10	Ring chromosome in a case of acute myelomonocytic leukemia: its significance and a review of the literature. 1987 ·PubMed ·J. Whang‐Peng,(unknown),(unknown),GP Schechter	7
11	Cytogenetic Studies in Human T-cell Lymphoma Virus (HTLV)-Positive Leukemia-Lymphoma in the United States 1985 ·JNCI Journal of the National Cancer Institute ·J. Whang‐Peng,Bunn Pa,Turid Knutsen,(unknown),S Broder,ES Jaffe,E P Gelmann,William A. Blattner,W. Lofters,Young Rc,(unknown)	38
12	Acute megakaryoblastic leukemia in childhood 1984 ·Cancer ·Eric Sariban,Constance Oliver,(unknown),Jeffrey Cossman,J. Whang‐Peng,Elaine S. Jaffe,Harvey R. Gralnick,David G. Poplack	46
13	Embryotoxicity in mice of phosphonacetyl‐L‐aspartic acid (PALA), a new antitumor agent. I. Embryolethal, teratogenic, and cytogenetic effects 1980 ·Teratology ·S. M. Sieber,(unknown),(unknown),Elaine C. Lee,J. Whang‐Peng	9
14	Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·J. Whang‐Peng,Paul A. Bunn,Tor Knutsen,GP Schechter,Adi F. Gazdar,Mary J. Matthews,John D. Minna	39
15	Myeloproliferative syndromes: a unique presentation of chronic myelogenous leukemia (CML) as a primary tumor of bone 1978 ·Blood ·DL Longo,J. Whang‐Peng,Elaine S. Jaffe,(unknown),RC Young	9
16	Cytogenetic studies in L2C leukemia. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·J. Whang‐Peng	0
17	Small F chromosome in myelo- and lymphoproliferative diseases 1977 ·Leukemia Research ·J. Whang‐Peng,(unknown),Tor Knutsen,Harmar D. Brereton,Pyung Hun Chang,GP Schechter,Lawrence S. Lessin	15
18	Preparation of mononuclear cell subpopulations from normal human peripheral blood. 1977 ·PubMed ·(unknown),J. Whang‐Peng,Sara Perry	12
19	Unusual Clonal Evolution in a Case of Chronic Myelogenous Leukemia 1976 ·Acta Haematologica ·J. Whang‐Peng,S Broder,(unknown),Robert C. Young	5
20	CYTOGENETICALLY ABNORMAL CELL S IN VITRO IN ACUTE LEUKÆMIA 1972 ·The Lancet ·(unknown),J. M. C. Bull,J. Whang‐Peng,Paul P. Carbone	36

About J. Whang‐Peng

J. Whang‐Peng is a scholar working on Hematology, Genetics and Oncology, having authored 46 papers that have together received 2.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), DNA Repair Mechanisms (7 papers) and Acute Lymphoblastic Leukemia research (7 papers). The work is most often cited by research in Hematology (456 citations), Oncology (867 citations) and Cancer Research (327 citations). J. Whang‐Peng has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include C. S. Kao-Shan, Adi F. Gazdar, John D. Minna, Paul A. Bunn, D. N. Carney, Tor Knutsen, Merrill E. Goldsmith, Kenneth H. Cowan, Ira Pastan and Antonio Tito Fojo. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact